2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$33.07+$0.24 (+0.73%)
Price as of Oct 02, 2026 6:06 PM EDT- $1.6BMarket Cap
- 15.03%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$33.07+$0.24 (+0.73%)
RAPP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.83 | ||
Change | -$0.77 (-2.29%) | ||
Open | $33.52 | ||
High | $34.31 | ||
Low | $32.80 | ||
Previous Close | $33.60 | ||
Volume | 326,777 | ||
30-Day Average Volume | 480,667 | ||
1-Week Change | -2.96% | ||
1-Month Change | -32.39% | ||
1-Year Change | 15.03% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.0M | ||
Total Assets | $459.0M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$56.6M | ||
Free Cash Flow | -$41.5M | ||
EBIT | -$56.6M | ||
EBITDA | -$56.4M | ||
Net Working Capital | $418.4M | ||
EPS | -$1.19 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -28 | ||
PEG | 0 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue